• Orionis Biosciences secures $55 million financing to support advancement into clinic

    Wednesday October 19th 2022

  • Univercells raises € 44 million in first close of its Series D

    Wednesday October 19th 2022

  • Rewind Therapeutics appoints Irene Knuesel, PhD, as Chief Scientific Officer

    Wednesday October 19th 2022

  • Sanofi investeert 120 miljoen in productie van biologische geneesmiddelen in Geel

    Wednesday October 19th 2022

  • Kantify and Mcule harness the power of data to accelerate drug discovery

    Monday October 17th 2022

  • Mithra announces positive preclinical data demonstrating Estetrol’s efficacy in wound healing

    Wednesday October 12th 2022

  • KU Leuven researchers discover possible new treatment method for metastatic prostate cancer

    Tuesday October 11th 2022

  • Biocartis initiates commercialization in Europe of HepatoPredict (CE-IVD) test for liver cancer patients

    Monday October 10th 2022

  • Your news here?

  • Ziphius Vaccines and UZ Ghent establish unique collaboration for GMP manufacturing of saRNA-based vaccines

    Friday October 7th 2022

  • Bone Therapeutics to regain worldwide rights to ALLOB

    Friday October 7th 2022

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    Tuesday October 4th 2022

Strategic Partners